16-hydroxycleroda-3,13(14)-dien-15,16-olide has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, CH; Lin, SX; Thiyagarajan, V; Weng, CF | 1 |
| Sivalingam, KS; Thiyagarajan, V; Viswanadha, VP; Weng, CF | 1 |
2 other study(ies) available for 16-hydroxycleroda-3,13(14)-dien-15,16-olide and Glioma
| Article | Year |
|---|---|
A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Survival; Coated Materials, Biocompatible; Delayed-Action Preparations; Diterpenes; Drug Carriers; Drug Liberation; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Hydrogen-Ion Concentration; Male; Mice, Nude; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Polymethacrylic Acids; Protein Kinase Inhibitors; Rats; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; X-Ray Diffraction; Xenograft Model Antitumor Assays | 2016 |
16-hydroxy-cleroda-3,13-dien-16,15-olide induced glioma cell autophagy via ROS generation and activation of p38 MAPK and ERK-1/2.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autophagy; Cell Line, Tumor; Diterpenes; Glioma; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Polyalthia; Rats; Reactive Oxygen Species | 2016 |